Search results for "philia"

showing 10 items of 299 documents

Management of dental extraction in patients with Haemophilia A and B: a report of 58 extractions

2013

Objectives: Patients with inherited bleeding disorders are at high risk of bleeding following oral surgery and present challenges to the oral surgeons. Aim of this study was to report our experience in dental extraction in patients exhibiting Haemophilia A and B between 2007 and 2012. Patient and Methods: 58 dental extractions in 15 patients during 19 interventions were performed. Replacement therapy with recombinant and plasma-derived factor VIII and IX was applied systematically in combination with antifibrinolytic treatment and local haemostatic measures. The following data were recorded: type of surgery, applied local haemostatic measures, general substitution, systemic antifibrinolytic…

AdultMalemedicine.medical_specialtyAntifibrinolyticAdolescentOral Surgeonmedicine.drug_classmedicine.medical_treatmentHaemophilia AOdontologíaPostoperative HemorrhageHaemophiliaHemophilia AHemophilia BHemostaticsYoung AdultAntifibrinolytic agentmedicineHumansChildGeneral DentistryAgedbusiness.industryHemostatic TechniquesResearchMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludSurgeryHemostaticsOtorhinolaryngologyDental extractionChild PreschoolTooth ExtractionUNESCO::CIENCIAS MÉDICASSurgeryFemaleTamponadeOral Surgerybusiness
researchProduct

Coexistence of thrombophilic gene polymorphisms among 559 unrelated consecutive patients with a history of thrombosis.

2001

AdultMalemedicine.medical_specialtyBiologyGastroenterologyGenetic determinismPolymorphism (computer science)Risk FactorsInternal medicineFactor V LeidenmedicineHumansThrombophiliaGeneMethylenetetrahydrofolate Reductase (NADPH2)GeneticsVenous ThrombosisOxidoreductases Acting on CH-NH Group DonorsPolymorphism GeneticVascular diseaseFactor VThrombosisHematologyMiddle Agedmedicine.diseaseThrombosisCase-Control StudiesFemaleProthrombinThrombosis research
researchProduct

Physical Activity Monitoring and Acceptance of a Commercial Activity Tracker in Adult Patients with Haemophilia.

2019

Physical activity (PA) is highly beneficial for people with haemophilia (PWH), however, studies that objectively monitor the PA in this population are scarce. This study aimed to monitor the daily PA and analyse its evolution over time in a cohort of PWH using a commercial activity tracker. In addition, this work analyses the relationship between PA levels, demographics, and joint health status, as well as the acceptance and adherence to the activity tracker. Twenty-six PWH were asked to wear a Fitbit Charge HR for 13 weeks. According to the steps/day in the first week, data were divided into two groups: Active Group (AG

AdultMalemedicine.medical_specialtyDemographicsHealth Toxicology and MutagenesisPopulationPhysical activitylcsh:Medicinephysical activityFitness Trackers030204 cardiovascular system & hematologyHaemophiliaHemophilia AArticle03 medical and health sciences0302 clinical medicinefitness trackerSurveys and QuestionnairesArthropathyMedicineHumans030212 general & internal medicineeducationMonitoring Physiologiceducation.field_of_studyMotivationAdult patientsexercisebusiness.industryActivity trackerlcsh:RPublic Health Environmental and Occupational Healthhaemophilic arthropathyMiddle Agedmedicine.diseaseCohortPhysical therapyPatient ComplianceFemalebusinessInternational journal of environmental research and public health
researchProduct

A prospective randomized trial of high and standard dosages of recombinant factor VIIa for treatment of hemarthroses in hemophiliacs with inhibitors.

2006

Summary. Aim: A multicenter randomized open-label crossover prospective trial was designed to compare the efficacy, safety, and cost of standard and high dosages of recombinant factor VIIa (rFVIIa) for home treatment of hemarthroses in hemophiliacs with inhibitors. Methods: Patients were instructed to treat, within 6 h from the onset of bleeding, four consecutive hemarthroses of ankles, knees, or elbows, either with the rFVIIa standard dose of 90 μg kg−1 (repeated as necessary every 3 h) or with a single high dose of 270 μg kg−1. Patients who did not achieve a clinical success within 9 h continued rFVIIa treatment with repeated standard doses. Response to treatment was assessed for up to 48…

AdultMalemedicine.medical_specialtyDoseAdolescentVisual analogue scaleFactor VIIaHemophilia Alaw.inventionRandomized controlled triallawSingle high doseHemarthrosisMedicineHumansProspective StudiesProspective cohort studyChildCross-Over Studiesbiologybusiness.industryInfantHematologyMiddle AgedCrossover studyRecombinant ProteinsSurgeryRegimenRecombinant factor VIIaChild Preschoolbiology.proteinSafetybusinessJournal of thrombosis and haemostasis : JTH
researchProduct

Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma

2018

Background Mepolizumab has demonstrated favorable safety and efficacy profiles in placebo-controlled trials of 12 months' duration or less; however, long-term data are lacking. Objective We sought to evaluate the long-term safety and efficacy of mepolizumab in patients with severe eosinophilic asthma (SEA). Methods COLUMBA (Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects, NCT01691859 ) was an open-label extension study in patients with SEA previously enrolled in DREAM (Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma, NCT01000506 ). Patients received 100 mg of subcutaneous mepolizumab every 4 weeks plus standard of care until a protocol-def…

AdultMalemedicine.medical_specialtyDrug-Related Side Effects and Adverse ReactionsExacerbationInjections Subcutaneous[SDV]Life Sciences [q-bio]ImmunologyEosinophilic asthmaAntibodies Monoclonal HumanizedPlacebos03 medical and health sciences0302 clinical medicineDouble-Blind MethodSurveys and QuestionnairesInternal medicineEosinophiliamedicineHumansImmunology and AllergyIn patientAnti-Asthmatic Agents030212 general & internal medicineAdverse effectRespiratory Tract InfectionsComputingMilieux_MISCELLANEOUSAsthmabusiness.industryMiddle Agedmedicine.diseaseAsthma3. Good healthEosinophils[SDV] Life Sciences [q-bio]Treatment Outcome030228 respiratory systemAsthma Control QuestionnaireBronchitisFemaleInterleukin-5businessMepolizumabmedicine.drug
researchProduct

Genetic predisposition to thrombophilia in inflammatory bowel disease

2011

BACKGROUND Inflammatory bowel disease (IBD) is linked to a definite risk of thromboembolic events (TE), but data on the role of prothrombotic genetic mutations are conflicting. STUDY Fourteen genetic factors involved in TE pathogenesis were investigated in a homogeneous cohort of Sicilian patients with IBD with and without history of TE and in healthy controls. Forty IBD patients (21 CD, 19 UC) and 20 healthy individuals were enrolled. Genetic testing was based on the reverse hybridization principle by a commercial assay that analyzes 14 polymorphisms involved in thrombophilia and cholesterol metabolism. The rate of genetic polymorphisms and mutations was compared between IBD patients and h…

AdultMalemedicine.medical_specialtyIBDAngiotensinogenPeptidyl-Dipeptidase AThrombophiliaInflammatory bowel diseaseGastroenterologyPolymorphism (computer science)Risk FactorsInternal medicineDiabetes mellitusGenotypeGenetic predispositionmedicineHumansThrombophiliaGenetic Predisposition to DiseaseAllele frequencySicilyGenetic testingAgedPolymorphism Geneticmedicine.diagnostic_testbusiness.industryGastroenterologyMiddle Agedmedicine.diseaseInflammatory Bowel Diseasesdigestive system diseasesMutationFemalebusiness
researchProduct

Thrombus-like small apical fibroma in patient with left ventricular dysfunction and thrombophilia: an unusual presentation.

2016

AdultMalemedicine.medical_specialtyPathologyMagnetic Resonance Imaging CineFibroma030204 cardiovascular system & hematologyThrombophiliacardiac magnetic resonanceHeart Neoplasms03 medical and health sciencesVentricular Dysfunction Left0302 clinical medicineCardiac fibromacardiac fibromacardiac maInternal medicinemedicineHumansThrombophiliaIn patientThrombusmedicine.diagnostic_testbusiness.industryMagnetic resonance imagingThrombosisGeneral Medicinemedicine.diseaseThrombosisCardiac Imaging Techniques030220 oncology & carcinogenesisCardiologyFibromaPresentation (obstetrics)businessCardiology and Cardiovascular MedicineJournal of cardiovascular medicine (Hagerstown, Md.)
researchProduct

Prevention of haemophilic arthropathy during childhood. May common orthopaedic management be extrapolated from patients without inhibitors to patient…

2008

We recommend prophylaxis in haemophilic children with an inhibitor as a way of preventing the musculoskeletal impairment that is likely to affect them. This approach has been used for children without inhibitors with excellent results. If prophylaxis is not feasible, we suggest that intensive on-demand treatment should be given. Two agents, recombinant activated FVII (rFVIIa) and activated prothrombin complex concentrates (aPCC), are currently used to control haemostasis either for prophylaxis or intensive on-demand treatment. As it is recombinant, rFVIIa would seem more appropriate to be employed in children. aPCC could be used in adults, or in the event of an unsatisfactory response to rF…

AdultMalemedicine.medical_specialtyPediatricsTime FactorsEvidence-based practiceAdolescentFactor VIIaHemophilia AHaemophiliaFactor IXYoung AdultHemarthrosismedicineOrthopaedic proceduresHumansPain ManagementOrthopedic ProceduresChildIntensive care medicinePhysical Therapy ModalitiesGenetics (clinical)Randomized Controlled Trials as TopicRetrospective StudiesHaemophilic arthropathySynovitisBlood Coagulation Factor InhibitorsCoagulantsbusiness.industryMusculoskeletal impairmentHematologyGeneral MedicinePerioperativemedicine.diseaseSkeletal maturityBlood Coagulation FactorsRecombinant ProteinsCartilageTreatment OutcomeChild PreschoolPractice Guidelines as TopicbusinessPROTHROMBIN COMPLEXHaemophilia : the official journal of the World Federation of Hemophilia
researchProduct

Effects of electrical stimulation on muscle trophism in patients with hemophilic arthropathy.

2009

Abstract Gomis M, Gonzalez L-M, Querol F, Gallach JE, Toca-Herrera J-L. Effects of electrical stimulation on muscle trophism in patients with hemophilic arthropathy. Objective To determine changes occurring in the cross-sectional area, electromyography (EMG) activity, and the strength of the biceps brachii after an 8-week period of bilateral training with surface muscle electrical stimulation in patients with hemophilic arthropathy. Design Controlled trial. Setting Coagulopathy unit, university hospital. Participants Volunteer subjects (N=30) participated in this study: 15 with severe hemophilia A (hemophilic group) and 15 nonhemophilic control subjects (control group). Interventions The he…

AdultMalemedicine.medical_specialtyPhysical Therapy Sports Therapy and RehabilitationStimulationPhysical exerciseElectric Stimulation TherapyIsometric exerciseElectromyographyPhysical strengthHemophilia ABicepsMuscle hypertrophyPhysical medicine and rehabilitationArthropathymedicineHumansMuscle Skeletalmedicine.diagnostic_testbusiness.industryElectromyographyRehabilitationMiddle Agedmedicine.diseaseTreatment OutcomeFemaleJoint DiseasesbusinessArchives of physical medicine and rehabilitation
researchProduct

Effects of performing dual tasks on postural sway and postural control complexity in people with haemophilic arthropathy

2019

Introduction People with haemophilic arthropathy (PWHA) have impairments in postural control. However, little is known about the effects of demanding conditions, including the unipedal stance and dual tasks, on postural control in PWHA. Aim Determine the effects of performing dual tasks while in the one-leg stance on postural sway and postural control complexity in PWHA vs. healthy active (HAG) and non-active (HNAG) groups of individuals. Methods Fifteen PWHA and 34 healthy subjects (18 active and 16 non-active) were recruited. Vertical (V), mediolateral (ML) and anteroposterior (AP) centre of mass signals were acquired using a 3-axis accelerometer placed at the L3/L4 vertebrae of subjects …

AdultMalemedicine.medical_specialtyPoison control030204 cardiovascular system & hematologyHemophilia APostural controlYoung Adult03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationmedicineHumansPostural BalanceGenetics (clinical)Balance (ability)Haemophilic arthropathybusiness.industryHealthy subjectsMotor controlHematologyGeneral MedicineSample entropyCase-Control StudiesHealthy individualsFemaleJoint Diseasesbusiness030215 immunologyHaemophilia
researchProduct